Stay updated on Preop ICI in Primary & Recurrent SCCHN Clinical Trial
Sign up to get notified when there's something new on the Preop ICI in Primary & Recurrent SCCHN Clinical Trial page.

Latest updates to the Preop ICI in Primary & Recurrent SCCHN Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new study on Head and Neck Squamous Cell Carcinoma, including changes in the study's cohorts and the involvement of Bristol-Myers Squibb as a collaborator. The total number of patients to be accrued has been clarified to 24, with adjustments based on enrollment speed.SummaryDifference50%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Preop ICI in Primary & Recurrent SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preop ICI in Primary & Recurrent SCCHN Clinical Trial page.